Fidelity Investments’s Labcorp LH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$344M Sell
1,288,411
-51,334
-4% -$13.9M 0.02% 644
2025
Q4
$336M Sell
1,339,745
-108,492
-7% -$28.8M 0.02% 656
2025
Q3
$416M Sell
1,448,237
-226,732
-14% -$60.7M 0.02% 575
2025
Q2
$440M Sell
1,674,969
-59,191
-3% -$14.4M 0.02% 537
2025
Q1
$404M Buy
1,734,160
+113,334
+7% +$27.5M 0.03% 534
2024
Q4
$372M Buy
1,620,826
+34,429
+2% +$7.9M 0.02% 578
2024
Q3
$355M Buy
1,586,397
+230,708
+17% +$50.7M 0.02% 602
2024
Q2
$276M Buy
1,355,689
+258,081
+24% +$52.5M 0.02% 667
2024
Q1
$240M Sell
1,097,608
-32,815
-3% -$7.23M 0.02% 721
2023
Q4
$257M Buy
1,130,423
+64,632
+6% +$13.6M 0.02% 654
2023
Q3
$214M Sell
1,065,791
-221,666
-17% -$46.8M 0.02% 667
2023
Q2
$267M Buy
1,287,457
+111,985
+10% +$21.7M 0.02% 618
2023
Q1
$232M Buy
1,175,472
+471,324
+67% +$97M 0.02% 652
2022
Q4
$142M Sell
704,148
-725,598
-51% -$142M 0.01% 828
2022
Q3
$252M Sell
1,429,746
-160,236
-10% -$32.8M 0.03% 590
2022
Q2
$320M Buy
1,589,982
+55,292
+4% +$11.8M 0.03% 529
2022
Q1
$348M Buy
1,534,690
+169,136
+12% +$39.8M 0.03% 563
2021
Q4
$369M Sell
1,365,554
-139,495
-9% -$34.5M 0.03% 557
2021
Q3
$364M Sell
1,505,049
-282,909
-16% -$71.3M 0.03% 551
2021
Q2
$424M Sell
1,787,958
-710,641
-28% -$162M 0.03% 495
2021
Q1
$547M Buy
2,498,599
+517,037
+26% +$104M 0.05% 399
2020
Q4
$347M Buy
1,981,562
+32,535
+2% +$5.62M 0.03% 525
2020
Q3
$315M Buy
1,949,027
+358,040
+23% +$56.7M 0.03% 454
2020
Q2
$227M Sell
1,590,987
-59,070
-4% -$8.17M 0.03% 562
2020
Q1
$179M Buy
1,650,057
+17,003
+1% +$2.45M 0.02% 540
2019
Q4
$237M Sell
1,633,054
-51,603
-3% -$7.45M 0.03% 588
2019
Q3
$243M Sell
1,684,657
-3,751
-0.2% -$547K 0.03% 563
2019
Q2
$251M Sell
1,688,408
-170,103
-9% -$23.7M 0.03% 569
2019
Q1
$244M Buy
1,858,511
+834,242
+81% +$103M 0.03% 572
2018
Q4
$111M Buy
1,024,269
+229,522
+29% +$30.7M 0.02% 802
2018
Q3
$119M Buy
794,747
+106,385
+15% +$16.2M 0.01% 881
2018
Q2
$106M Sell
688,362
-331,606
-33% -$50.1M 0.01% 925
2018
Q1
$142M Sell
1,019,968
-196,744
-16% -$28.9M 0.02% 834
2017
Q4
$167M Sell
1,216,712
-539,965
-31% -$71.4M 0.02% 766
2017
Q3
$228M Sell
1,756,677
-316,349
-15% -$42.2M 0.03% 628
2017
Q2
$275M Buy
2,073,026
+178,728
+9% +$21.9M 0.03% 550
2017
Q1
$233M Sell
1,894,298
-294,369
-13% -$34.9M 0.03% 631
2016
Q4
$241M Sell
2,188,667
-464,496
-18% -$51.6M 0.03% 593
2016
Q3
$313M Sell
2,653,163
-57,819
-2% -$6.81M 0.04% 475
2016
Q2
$303M Buy
2,710,982
+345,362
+15% +$37.2M 0.04% 493
2016
Q1
$238M Sell
2,365,620
-100,657
-4% -$9.65M 0.03% 570
2015
Q4
$262M Sell
2,466,277
-105,466
-4% -$10.9M 0.04% 540
2015
Q3
$240M Buy
2,571,743
+983,337
+62% +$102M 0.03% 550
2015
Q2
$165M Buy
1,588,406
+871,426
+122% +$90.7M 0.02% 793
2015
Q1
$77.7M Buy
716,980
+156,406
+28% +$16.1M 0.01% 1145
2014
Q4
$52M Buy
560,574
+316,042
+129% +$27.9M 0.01% 1309
2014
Q3
$21.4M Sell
244,532
-13,370
-5% -$1.21M ﹤0.01% 1708
2014
Q2
$22.7M Sell
257,902
-93,007
-27% -$8.06M ﹤0.01% 1740
2014
Q1
$29.6M Sell
350,909
-55,151
-14% -$4.4M ﹤0.01% 1580
2013
Q4
$31.9M Sell
406,060
-7,837
-2% -$668K ﹤0.01% 1531
2013
Q3
$35.3M Sell
413,897
-154,432
-27% -$13M 0.01% 1445
2013
Q2
$48.9M Buy
+568,329
New +$47.2M 0.01% 1257

Other funds holding LH

Fidelity Investments's LH Position: Q1 2026 in Review

Fidelity Investments reduced its Labcorp (LH) stake by 3.8% in Q1 2026, selling an estimated $13.9M and leaving 1,288,411 shares worth $344M. The position accounts for 0.02% of the portfolio, ranked #644.

Fidelity Investments first reported a position in LH in Q2 2013 and has held it in 52 quarters since. The position peaked at $547M in Q1 2021. 1,031 funds tracked by Wall St. Rank hold LH as of Q1 2026.

  • Fidelity Investments held 1,288,411 shares of Labcorp worth $344M as of Q1 2026.
  • Fidelity Investments sold 51,334 Labcorp shares in Q1 2026, an estimated $13.9M.
  • Labcorp made up 0.02% of Fidelity Investments's portfolio in Q1 2026, its #644 holding.
  • Fidelity Investments first reported a position in Labcorp in Q2 2013 and has held it in 52 quarters since.
  • Fidelity Investments's Labcorp position peaked at $547M in Q1 2021.
  • 1,031 funds tracked by Wall St. Rank held Labcorp as of Q1 2026.

Based on Fidelity Investments's 13F filing for Q1 2026, filed 15 May 2026.